US Drug Recall Register
Class III · Low risk Terminated Initiated May 17, 2012 (14 years ago)

Imodium Multi-Symptom Relief Caplets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective Container; damaged blister units

What was recalled

Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA

Recalling firm
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1404-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Loperamide recalls

See all
Class II · Moderate risk Terminated

Loperamide Hydrochloride capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-2100-01 D-1092-2022
Class III · Low risk Terminated

Loperamide HCL Tablets USP

Reason Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.

Sun Pharmaceutical Industries, Inc. D-0391-2019